Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Kenvue Inc. (NYSE:KVUE) has received a consensus rating of "Hold" from twelve analysts, with seven holding this position and five recommending a buy.
• The company reported earnings of $0.24 EPS for the last quarter, surpassing analysts' expectations, but revenue decreased by 3.9% year-over-year.
• Kenvue has raised its quarterly dividend to $0.2075 per share, reflecting an annualized yield of 3.9%, despite a high payout ratio of 149.09%.

Kenvue Inc. (NYSE:KVUE - Get Free Report) has been given a consensus rating of "Hold" by the twelve ratings firms that are currently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $24.3750.

A number of analysts have weighed in on the company. UBS Group cut their price target on Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Royal Bank Of Canada cut their price target on Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research note on Friday. JPMorgan Chase & Co. cut their target price on Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. Barclays cut their target price on Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 15th. Finally, Bank of America cut their target price on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th.

Kenvue Stock Down 1.8%

Kenvue stock traded down $0.39 during midday trading on Thursday, reaching $21.37. The company's stock had a trading volume of 25,925,024 shares, compared to its average volume of 21,613,902. Kenvue has a fifty-two week low of $19.75 and a fifty-two week high of $25.17. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market cap of $41.00 billion, a P/E ratio of 28.88, a P/E/G ratio of 3.65 and a beta of 0.83. The business has a 50-day simple moving average of $21.62 and a 200-day simple moving average of $22.40.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.36% and a net margin of 9.37%. The company had revenue of $3.84 billion for the quarter, compared to analysts' expectations of $3.94 billion. During the same period last year, the firm earned $0.32 earnings per share. Kenvue's quarterly revenue was down 4.0% on a year-over-year basis. On average, research analysts expect that Kenvue will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be issued a dividend of $0.2075 per share. This is an increase from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date of this dividend is Wednesday, August 13th. Kenvue's dividend payout ratio is 112.16%.

Institutional Investors Weigh In On Kenvue

A number of institutional investors have recently added to or reduced their stakes in the business. Evergreen Wealth Solutions LLC grew its holdings in Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after buying an additional 432 shares during the last quarter. Fulton Bank N.A. grew its holdings in Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock valued at $1,892,000 after buying an additional 465 shares during the last quarter. Scott & Selber Inc. grew its holdings in Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after buying an additional 475 shares during the last quarter. Wealth Alliance LLC grew its holdings in Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after buying an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA grew its holdings in Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after buying an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.